Atopic Dermatitis Diagnostic Criteria and Outcome Measures for Clinical Trials: Still a Mess
Author:
Open Access
- 1 March 2011
- journal article
- editorial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 131 (3) , 557-559
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Core Outcome Domains for Controlled Trials and Clinical Recordkeeping in Eczema: International Multiperspective Delphi Consensus ProcessJournal of Investigative Dermatology, 2011
- Global variations in prevalence of eczema symptoms in children from ISAAC Phase ThreeJournal of Allergy and Clinical Immunology, 2009
- Diagnostic criteria for atopic dermatitis: a systematic reviewBritish Journal of Dermatology, 2008
- What are the best outcome measurements for atopic eczema? A systematic reviewJournal of Allergy and Clinical Immunology, 2007
- OMERACT: An international initiative to improve outcome measurement in rheumatologyTrials, 2007
- Quality of life in infants and children with atopic dermatitis: Addressing issues of differential item functioning across countries in multinational clinical trialsHealth and Quality of Life Outcomes, 2007
- Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003Journal of Allergy and Clinical Immunology, 2004
- Measuring Atopic Dermatitis Severity in Randomized Controlled Clinical Trials: What Exactly Are We Measuring?Journal of Investigative Dermatology, 2003
- Allergic diseases, skin prick test responses, and IgE levels in North Karelia, Finland, and the Republic of Karelia, RussiaJournal of Allergy and Clinical Immunology, 2002
- A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task forceAllergy, 2001